SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001628280-21-020527
Filing Date
2021-10-26
Accepted
2021-10-26 16:33:24
Documents
1
Period of Report
2021-10-25

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_163528039067523.html 4  
1 FORM 4 wf-form4_163528039067523.xml 4 7553
  Complete submission text file 0001628280-21-020527.txt   8908
Mailing Address #1203-4464 MARKHAM STREET VICTORIA BC A1 V8Z 7X8
Business Address #1203-4464 MARKHAM STREET VICTORIA BC A1 V8Z 7X8 250-708-4272
Aurinia Pharmaceuticals Inc. (Issuer) CIK: 0001600620 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A0 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address #1203-4464 MARKHAM STREET VICTORIA A1 BC V8Z7X8
Business Address
Huizinga Robert Bindert (Reporting) CIK: 0001837648 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36421 | Film No.: 211349016